0000885590-12-000034.txt : 20120530
0000885590-12-000034.hdr.sgml : 20120530
20120530165158
ACCESSION NUMBER: 0000885590-12-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120525
FILED AS OF DATE: 20120530
DATE AS OF CHANGE: 20120530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAUL LAURENCE E
CENTRAL INDEX KEY: 0001190966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 12878217
MAIL ADDRESS:
STREET 1: LAURE CROWN VENTURE 1620 26TH ST
STREET 2: SOUTH TOWER SUITE 300
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0305
4
2012-05-25
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001190966
PAUL LAURENCE E
4787 LEVY ROAD
MONTREAL
A8
H4R 2P9
QUEBEC, CANADA
1
0
0
0
Common Shares, no par value
2012-05-25
4
P
0
5000
48.6
A
47397
D
Common Shares, no par value
2012-05-29
4
P
0
700
48
A
48097
D
This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1.
by: Nicholas Zanoni for Laurence Paul
2012-05-30